Dingheng Lu

653 total citations
16 papers, 478 citations indexed

About

Dingheng Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dingheng Lu has authored 16 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dingheng Lu's work include Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (3 papers). Dingheng Lu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (3 papers). Dingheng Lu collaborates with scholars based in China, Japan and Hong Kong. Dingheng Lu's co-authors include Minuo Yin, Yajie Li, Ying Gao, Meirong Shan, Xuexiang Li, Liang Chen, Lulin Cheng, Yarong Song, Yunxue Li and Ying Yu and has published in prestigious journals such as Human Reproduction, Cell Reports and Cancer Letters.

In The Last Decade

Dingheng Lu

13 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dingheng Lu China	9	300	219	203	65	65	16	478
Rui Gou China	16	367 1.2×	248 1.1×	144 0.7×	120 1.8×	69 1.1×	28	547
Yuexin Hu China	16	345 1.1×	247 1.1×	141 0.7×	115 1.8×	65 1.0×	36	527
Minuo Yin China	8	265 0.9×	212 1.0×	132 0.7×	42 0.6×	82 1.3×	9	440
Yuandong Liao China	11	337 1.1×	320 1.5×	67 0.3×	90 1.4×	46 0.7×	19	499
Chengjuan Jin China	13	216 0.7×	116 0.5×	55 0.3×	79 1.2×	89 1.4×	21	420
Xiulan Zheng China	13	397 1.3×	308 1.4×	276 1.4×	148 2.3×	67 1.0×	14	637
Shanyang He China	13	407 1.4×	253 1.2×	46 0.2×	132 2.0×	47 0.7×	23	552
Saravut J. Weroha United States	8	223 0.7×	85 0.4×	94 0.5×	136 2.1×	29 0.4×	19	349
Hongluan Mao China	14	234 0.8×	164 0.7×	38 0.2×	129 2.0×	62 1.0×	22	458
Véronique Barrès Canada	10	212 0.7×	82 0.4×	59 0.3×	99 1.5×	36 0.6×	19	373

Countries citing papers authored by Dingheng Lu

Since Specialization

Citations

This map shows the geographic impact of Dingheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingheng Lu more than expected).

Fields of papers citing papers by Dingheng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingheng Lu. The network helps show where Dingheng Lu may publish in the future.

Co-authorship network of co-authors of Dingheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Dingheng Lu. A scholar is included among the top collaborators of Dingheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingheng Lu. Dingheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wang, Jiaming, Haiyun Xie, Zixiang Liu, et al.. (2025). KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway. Cell Reports. 44(5). 115595–115595.

Lu, Dingheng, Yuxiao Li, Yuchen Shi, et al.. (2025). miR-9-5p/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1/STAT1 signaling pathway. Journal of Translational Medicine. 23(1). 36–36. 4 indexed citations

Shi, Yuchen, Shan Huang, Dingheng Lu, et al.. (2025). Hypoxia-Induced Histone Lactylation Drives Cisplatin Resistance in Bladder Cancer by Promoting RBM15-Dependent m ⁶ A Methylation of IGFBP3. Research. 8. 970–970.

Wu, Yuqing, Yufan Ying, Fenghao Zhang, et al.. (2024). NSUN2-mediated R-loop stabilization as a key driver of bladder cancer progression and cisplatin sensitivity. Cancer Letters. 611. 217416–217416. 4 indexed citations

Shu, Xuan, Jiangfeng Li, Yufan Ying, et al.. (2024). N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. Cellular Signalling. 125. 111510–111510. 8 indexed citations

Li, Yuxiao, Shan Huang, W. Ju, et al.. (2024). Deciphering riddles in molecular subtyping of bladder cancer. Asian journal of urology. 12(2). 217–231.

Ma, Xueyou, Yufan Ying, Xuan Shu, et al.. (2024). N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis. Cancer Letters. 585. 216613–216613. 14 indexed citations

Lu, Dingheng, Yuxiao Li, Yuchen Shi, et al.. (2024). STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma. Research. 7. 539–539. 15 indexed citations

Yu, Ying, Bing Liu, Xuexiang Li, et al.. (2022). ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death and Disease. 13(1). 46–46. 53 indexed citations

10.

Lu, Dingheng, Tianbao Yang, Chenghan Li, et al.. (2022). A pH-Dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in Vitro/Vivo and apoptosis mechanism. European Journal of Medicinal Chemistry. 236. 114293–114293. 6 indexed citations

11.

Yu, Ying, Yarong Song, Lulin Cheng, et al.. (2022). CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 41(1). 188–188. 77 indexed citations

12.

Liu, Bing, Xuexiang Li, Decai Wang, et al.. (2022). CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis. Cancer Science. 113(6). 2056–2070. 35 indexed citations

13.

Lu, Dingheng, Yarong Song, Ying Yu, et al.. (2021). KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death and Disease. 12(8). 787–787. 30 indexed citations

14.

Liu, Bing, Yarong Song, Ying Yu, et al.. (2021). CEMIP-Mediated ITPR3/CaMKII/NRF2/SLC7A11 Pathway Promotes Ferroptosis Resistance of Prostate Cancer Cells During Extracellular Matrix Detachment. SSRN Electronic Journal. 1 indexed citations

15.

Li, Yajie, et al.. (2020). Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis. Human Reproduction. 36(4). 951–964. 212 indexed citations

16.

Lei, Chengyong, Shidong Lv, Hongyi Wang, et al.. (2018). Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein. DNA and Cell Biology. 37(8). 659–669. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact